Company intelligence / Profile preview
Vect-Horus
Marseille, Provence-Alpes-Côte d’Azur, Francevect-horus.com ↗
- Ownership
- Private
- Employees
- ~40
- Development stage
- Phase 1
01
Overview
Vect-Horus has demonstrated proof-of-concept for its vectorization technology in animal models for various modalities. The company’s lead programs are advancing toward clinical trials with at least one theragnostic agent entering the clinic. The company has secured major licensing deals and research collaborations with global pharma partners including Novo Nordisk and Janssen Pharmaceuticals. Its technology has shown promise for improving drug delivery to the brain and tumors by overcoming biological barriers like the BBB.[4][8]
- Therapeutic areas
- OncologyPulmonologyCardiovascularOphthalmologyNeurology
- Modalities
- Small molecules (via vectorization)Oligonucleotides (siRNAs, ASOs, mRNAs)Antibodies (vectorized mAbs)Nanoparticles
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Novo Nordisk – exclusive global license agreement on VECTrans® platform for specified targets ($327M+ potential milestones plus royalties)[4].Janssen Pharmaceuticals / Johnson & Johnson – research collaboration on drug delivery to CNS/tumors[8].Sanofi – collaboration on neurodegenerative disease therapeutics using vectorization technology[7].Advanced Accelerator Applications (AAA) – partnership in molecular/nuclear imaging agents targeting tumors/CNS.[7]
Beyond the preview
Go deeper on Vect-Horus.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vect-Horus.